Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-17

Clinical Trial Update: Oral vs Intravenous and Proton Pump Inhibitor (PPI)for Peptic Ulcer Bleeding (PUB) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral vs intravenous administration and PPI for peptic ulcer bleeding has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Changhua Christian Hospital | Conditions: Upper Gastrointestinal Bleeding | Phase 4 | Status: WITHDRAWN